What is the recommended treatment regimen after a Clostridioides difficile infection?

Treatment Post C. difficile Infection

After completing treatment for C. difficile infection, the primary focus should be on preventing recurrence through risk stratification and consideration of microbiota restoration therapy, rather than routine follow-up testing or prophylactic antibiotics. 1

Post-Treatment Management Strategy

Do NOT Perform Routine Test of Cure

• Testing should only be performed if diarrheal symptoms persist or worsen 2
• C. difficile can remain detectable in stool for weeks after successful treatment without clinical significance
• Testing asymptomatic patients leads to unnecessary treatment and confusion

Risk Assessment for Recurrence

After completing CDI treatment, immediately assess recurrence risk based on:

• Age >65 years
• Immunocompromised status (including immunosuppressive therapy)
• Severe CDI on initial presentation (WBC >15,000 cells/μL or creatinine >1.5× baseline)
• History of congestive heart failure (relevant for bezlotoxumab consideration)
• Ongoing need for systemic antibiotics 1

Specific Post-Treatment Interventions

For High-Risk Patients After Initial Episode

Consider microbiota restoration therapy even after the first episode if:

• The initial infection was particularly severe or difficult to treat
• Multiple high-risk factors are present
• Ongoing systemic antibiotics are required 2

For Patients After Severe/Fulminant CDI

Maintain suppressive vancomycin (125 mg daily) until outpatient fecal microbiota transplantation (FMT) can be administered to prevent recurrence in this extremely high-risk population 2

Bezlotoxumab Consideration

• 10 mg/kg IV once during antibiotic treatment can be considered for high-risk patients
• Caution: Reserved for patients when benefit outweighs risk in those with CHF history 1
• Limited data when combined with fidaxomicin

Environmental and Behavioral Counseling

Patient Education Should Include:

• Handwashing importance with soap and water (alcohol-based sanitizers are ineffective against C. difficile spores)
• Home disinfection of potentially contaminated areas using EPA-approved sporicidal agents (bleach-based products)
• Reassurance that transmission to unaffected family members is uncommon 2
• Avoid unnecessary antibiotics - this is critical counseling for all CDI survivors 2

Medication Review

• Evaluate proton pump inhibitor (PPI) use: If legitimate indication exists, discontinuation is not necessary; if no clear indication, consider stopping 2
• Do NOT use probiotics for preventing recurrence - they are not advised 2
• Avoid cholestyramine and bile acid-binding agents 2

Dietary Recommendations

Promote restoration of healthy gut microbiota through:

• Consuming a healthy diet with variety of fruits and vegetables
• Foods rich in both soluble and insoluble fiber
• Psyllium fiber can be used to bulk stools in patients who have recovered 2

Common Pitfalls to Avoid

1. Testing too soon after treatment completion - leads to false positives and unnecessary retreatment
2. Using vancomycin prophylaxis during systemic antibiotics - not advised for prevention 2
3. Delaying microbiota restoration therapy - current evidence favors earlier use in high-risk patients rather than waiting for multiple recurrences 2, 3
4. Prescribing metronidazole for subsequent episodes - no longer recommended when fidaxomicin or vancomycin are available 3

If Recurrence Occurs Within 8 Weeks

First Recurrence (Second Episode)

Preferred: Fidaxomicin 200 mg twice daily for 10 days, OR extended regimen (twice daily for 5 days, then every other day for 20 days) 1

Alternatives:

• Tapered and pulsed vancomycin regimen (125 mg 4× daily for 10-14 days, then 2× daily for 7 days, then daily for 7 days, then every 2-3 days for 2-8 weeks)
• Standard vancomycin 125 mg 4× daily for 10 days (especially if metronidazole was used initially)

Add bezlotoxumab for recurrence prevention in high-risk patients 1

Second or Subsequent Recurrence (Third+ Episode)

Fecal microbiota-based therapies should be offered after treatment of the second recurrence:

• FDA-approved products: fecal microbiota spores live-brpk (Vowst) or fecal microbiota live-jslm (Rebyota)
• Conventional FMT via colonoscopy
• Note: At least 2 recurrences (3 total CDI episodes) should be treated with antibiotics before offering FMT 1

For Patients Not Candidates for Microbiota Therapy

Prolonged suppressive vancomycin (125 mg daily) may be considered for secondary prophylaxis in patients with:

• Multiple recurrent episodes who cannot receive FMT
• Ongoing comorbidities or limited life expectancy
• Frequent systemic antibiotic requirements
• Failed multiple courses of microbiota-based therapy 2

The emphasis has shifted from repeated antibiotic cycling toward individualized recurrence prevention and earlier microbiota restoration 4, 3, making post-treatment risk assessment and proactive planning essential components of CDI management.